Search

Search Constraints

You searched for: Author/Creator Harrison, Douglas J.

Search Results

2. Clinical group and modified TNM stage for rhabdomyosarcoma: A review from the Children's Oncology Group. Issue 6 (6th March 2022)

4. Dose‐response effect of eribulin in preclinical models of osteosarcoma by the pediatric preclinical testing consortium. Issue 10 (24th July 2020)

5. Initial in vivo testing of a multitarget kinase inhibitor, regorafenib, by the Pediatric Preclinical Testing Consortium. Issue 6 (24th March 2020)

6. Metabolic response as assessed by 18F‐fluorodeoxyglucose positron emission tomography‐computed tomography does not predict outcome in patients with intermediate‐ or high‐risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee. (19th December 2020)

7. Patterns of failure and toxicity profile following proton beam therapy for pediatric bladder and prostate rhabdomyosarcoma. Issue 11 (9th August 2019)